1. Food and Drug Administration. Truvada® (Emtricitabine/Tenofovir disoproxil fumarate) for preexposure prophylaxis of HIV-1: Antiviral Drugs Advisory Committee Meeting Briefing Document. Retrieved from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AntiviralDrugsAdvisoryCommittee/UCM303216.pdf.

2. Gilead Sciences Inc. (2012) Truvada® (emtricitabine/tenofovir disoproxil fumarate): Prescribing Information. Retrieved from:  http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=54e82b13-a037-49ed-b4b3-030b37c0ecdd

3. Grant RM et al. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sec with Men. N Engl J Med. 2010 Dec 30;363(27): 2587-2599.

4. Baeten JM et al. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women. N Engl J Med. 2012 Jul 11:1-12

5. Food and Administration. FDA Approves First Medication to Reduce HIV Risk. Retrieved from: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm311821.htm.

6. PubMed Health website. Fanconi Syndrome. Available at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001374/.

7. Lexicomp Online. Emtricitabine and tenofovir pricing. Retrieved from: http://online.lexi.com.lecomlrc.lecom.edu/lco/action/doc/retrieve/docid/patch_f/6814. Accessed: Jul 24 2012.